Evidence map›Paper›PMID 39618630›Full record

ArticleCureus2024

Spontaneous Tumor Lysis Syndrome in the Setting of Pancreatic Adenocarcinoma.

Brendan M Coyne, Syed M Ishaq, Cameron J Coyne, Brandon S Shiflett, Joshua T Birnbaum

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brendan M CoyneInternal Medicine, George Washington University School of Medicine and Health Sciences, Washington, USA.
Syed M IshaqMedicine, Sinai Hospital of Baltimore, Baltimore, USA.
Cameron J CoyneBiology, University of California Riverside, Riverside, USA.
Brandon S ShiflettMedicine, Sinai Hospital of Baltimore, Baltimore, USA.
Joshua T BirnbaumInternal Medicine, Sinai Hospital of Baltimore, Baltimore, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor lysis syndrome (TLS) is the destruction of tumor cells, causing the release of intracellular contents, including but not limited to uric acid, phosphate, and potassium. This can manifest with significant physiologic abnormalities, such as life-threatening acute kidney injury. Although TLS is usually caused by the initiation of cytotoxic chemotherapy, it may also occur spontaneously, particularly in high-grade malignancies with high tumor burden and/or rapid cell turnover. Here, we present a case of spontaneous TLS in a patient with early-phase pancreatic cancer diagnosis and possible signs of metastasis. Additionally, we provide a comprehensive review of the current literature regarding this phenomenon. In the present case, our patient was stabilized using aggressive intravenous hydration and pharmacotherapy. This case report adds to the slowly growing literature surrounding the diagnosis and management of spontaneous TLS in pancreatic adenocarcinomas.

Indexed as

acute spontaneous tumor lysis syndromecritical care and internal medicineductal pancreatic adenocarcinomaelectrolyte imbalancegastro-hepatic-pancreato-biliary disordersmetabolic abnormalitiesoncologic emergenciesoncology and critical carepulmonary metastasis of pancreatic cancertumor lysis syndrome

Identifiers

PMID39618630
PMCPMC11606732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.